Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack, Mireille Mpoudi-Etame, Sandrine Leroy, Ségolène Perrineau, Martial Lantche Wandji, Darius Tetsa Tata, Pierette Omgba Bassega, Thérèse Abong Bwenda, Marie Varloteaux, Marcel Tongo, Eitel Mpoudi‐Ngolé, Alice Montoyo, Noémie Mercier, Vincent Le Moing, Martine Peeters, Jacques Reynes, Éric Delaporte, Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack, Mireille Mpoudi-Etame, Sandrine Leroy, Ségolène Perrineau, M Lantche-Wandji, D. Tetsa-Tata, P. Omgba-Bassega, T Abong-Bwenda, Marie Varloteaux, Marcel Tongo, Eitel Mpoudi‐Ngolé, Alice Montoyo, Noémie Mercier, V LeMoing, Martine Peeters, Jacques Reynes, Éric Delaporte, Ahidjo Ayouba, A Agholeng, Christelle Butel, Amandine Cournil, Sabrina Eymard‐Duvernay, Bruno Granouillac, S.R. Izard, André Lacroix, Laetitia Serrano, Nicole Vidal, PJ Fouda, R Mougnoutou, J Olinga, V Omgba, SC Tchokonte-Ngandé, B Ymele, CD Epoupa-Mpacko, Marie‐Jeannette Fotso, R Moukoko, T Nké, A Akamba, Skinner Lekelem, SB Tongo-Fotack, S Ngono, M. Tanga, E Ebong, G Edoul-Mbesse, Marcel Tongo, Laura Ciaffi, Sinata Koulla‐Shiro, Godfrey Manirakiza, E D Mimbé, Sylvie Boyer, Marwân‐al‐Qays Bousmah, Gwenaëlle Maradan, ML Nishimwe, Bruno Spire, MP Lê, Gilles Peytavin, Alpha Diallo, Isabelle Fournier, Claire Rekacewicz, Carmen Pérez Casas